KLEMP WALTER V bought MBRX
October 15, 2026 · Form 4 insider transaction
KLEMP WALTER V bought 415,000 shares of Moleculin Biotech, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
415,000
Price
N/A
Total value
N/A
InsiderKLEMP WALTER V
Role—
SecurityOptions (right to buy)
Transaction codeA: Grant or award
Transaction dateOctober 15, 2026
Filing dateOctober 16, 2026
Shares owned after2,341,335
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares withheld for payment of taxes upon vesting of restricted stock unit awards.; The stock option/restricted stock unit set forth in this table vests as follows: (i) 50% on grant; and (ii) 50% in 18 equal installments over 18 months.